No Data
ABOS Acumen Pharmaceuticals
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Acumen Pharmaceuticals Company
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Revenue Breakdown
News
Acumen Pharmaceuticals to Participate in the Cantor Global Healthcare Conference
CHARLOTTESVILLE, Va. and CARMEL, Ind., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble
Acumen Pharmaceuticals to Participate in the H.C. Wainwright Annual Global Investment Conference
CHARLOTTESVILLE, Va. and CARMEL, Ind., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble
Neurological Biomarkers Market Demand 2023, Key Players Analysis, Size, Share and Report By 2028
Comments
AH + 7/18 Watchlist ⚡️⚡️

rational Duck_7524 : time to sell?